| Item Type | Name |
|
Concept
|
Hematopoietic Stem Cells
|
|
Concept
|
Stem Cells
|
|
Concept
|
Tumor Stem Cell Assay
|
|
Concept
|
Hematopoietic Stem Cell Transplantation
|
|
Concept
|
Stem Cell Transplantation
|
|
Concept
|
Hematopoietic Stem Cell Mobilization
|
|
Concept
|
Peripheral Blood Stem Cell Transplantation
|
|
Concept
|
Stem Cell Factor
|
|
Concept
|
Adult Stem Cells
|
|
Concept
|
Myeloid Progenitor Cells
|
|
Concept
|
Cord Blood Stem Cell Transplantation
|
|
Concept
|
Neoplastic Stem Cells
|
|
Academic Article
|
Differentiation and erythropoietin receptor gene expression in human erythroid progenitor cells.
|
|
Academic Article
|
Abundance and stability of erythropoietin receptor mRNA in mouse erythroid progenitor cells.
|
|
Academic Article
|
Interferon gamma delays apoptosis of mature erythroid progenitor cells in the absence of erythropoietin.
|
|
Academic Article
|
Engagement of Gab1 and Gab2 in erythropoietin signaling.
|
|
Academic Article
|
Phosphorylation of forkhead transcription factors by erythropoietin and stem cell factor prevents acetylation and their interaction with coactivator p300 in erythroid progenitor cells.
|
|
Academic Article
|
Na pump isoforms in human erythroid progenitor cells and mature erythrocytes.
|
|
Academic Article
|
Fludarabine and melphalan-based conditioning for patients with advanced hematological malignancies relapsing after a previous hematopoietic stem cell transplant.
|
|
Academic Article
|
Cutting edge: activation of the p38 mitogen-activated protein kinase signaling pathway mediates cytokine-induced hemopoietic suppression in aplastic anemia.
|
|
Academic Article
|
Tetrodotoxin-sensitive Na+ channels and muscarinic and purinergic receptors identified in human erythroid progenitor cells and red blood cell ghosts.
|
|
Academic Article
|
Activation of the p38 mitogen-activated protein kinase mediates the suppressive effects of type I interferons and transforming growth factor-beta on normal hematopoiesis.
|
|
Academic Article
|
Safety and outcome after fludarabine-thiotepa-TBI conditioning for allogeneic transplantation: a prospective study of 30 patients with hematologic malignancies.
|
|
Academic Article
|
Regimen-related toxicity after fludarabine-melphalan conditioning: a prospective study of 31 patients with hematologic malignancies.
|
|
Academic Article
|
Stable transcriptional status in the apoptotic erythroid genome.
|
|
Academic Article
|
Osteopontin regulates actin cytoskeleton and contributes to cell proliferation in primary erythroblasts.
|
|
Academic Article
|
Successful autologous stem cell collection in patients with chronic myeloid leukemia in complete cytogenetic response, with quantitative measurement of BCR-ABL expression in blood, marrow, and apheresis products.
|
|
Academic Article
|
Phase II study of autologous transplantation with interleukin-2-incubated peripheral blood stem cells and posttransplantation interleukin-2 in relapsed or refractory non-Hodgkin lymphoma.
|
|
Academic Article
|
Loss of specific chaperones involved in membrane glycoprotein biosynthesis during the maturation of human erythroid progenitor cells.
|
|
Academic Article
|
Activation of protein kinase C{eta} by type I interferons.
|
|
Academic Article
|
Patterns and kinetics of T-cell chimerism after allo transplant with alemtuzumab-based conditioning: mixed chimerism protects from GVHD, but does not portend disease recurrence.
|
|
Academic Article
|
Reduced SMAD7 leads to overactivation of TGF-beta signaling in MDS that can be reversed by a specific inhibitor of TGF-beta receptor I kinase.
|
|
Academic Article
|
Aberrant epigenetic and genetic marks are seen in myelodysplastic leukocytes and reveal Dock4 as a candidate pathogenic gene on chromosome 7q.
|
|
Academic Article
|
Reduced-intensity conditioning with combined haploidentical and cord blood transplantation results in rapid engraftment, low GVHD, and durable remissions.
|
|
Academic Article
|
P. falciparum modulates erythroblast cell gene expression in signaling and erythrocyte production pathways.
|
|
Academic Article
|
Will cord blood stem cells come to the rescue of keratinocyte growth factor?
|
|
Academic Article
|
Distinct functions of erythropoietin and stem cell factor are linked to activation of mTOR kinase signaling pathway in human erythroid progenitors.
|
|
Academic Article
|
Erythroblast enucleation.
|
|
Academic Article
|
Pretreatment C-reactive protein is a predictor for outcomes after reduced-intensity allogeneic hematopoietic cell transplantation.
|
|
Academic Article
|
Purified CD34+ Lin- Thy+ stem cells do not contain clonal myeloma cells.
|
|
Academic Article
|
Changes in cytoskeletal proteins and their mRNAs during maturation of human erythroid progenitor cells.
|
|
Academic Article
|
Distinct roles of erythropoietin, insulin-like growth factor I, and stem cell factor in the development of erythroid progenitor cells.
|
|
Academic Article
|
CrkL and CrkII participate in the generation of the growth inhibitory effects of interferons on primary hematopoietic progenitors.
|
|
Academic Article
|
Activation of the Akt/FKHRL1 pathway mediates the antiapoptotic effects of erythropoietin in primary human erythroid progenitors.
|
|
Academic Article
|
Low incidence of CMV viremia and disease after allogeneic peripheral blood stem cell transplantation. Role of pretransplant ganciclovir and post-transplant acyclovir.
|
|
Academic Article
|
Fludarabine, melphalan, and alemtuzumab conditioning in adults with standard-risk advanced acute myeloid leukemia and myelodysplastic syndrome.
|
|
Academic Article
|
Older age but not donor health impairs allogeneic granulocyte colony-stimulating factor (G-CSF) peripheral blood stem cell mobilization.
|
|
Academic Article
|
Influence of related donor age on outcomes after peripheral blood stem cell transplantation.
|
|
Academic Article
|
Identifying familial myelodysplastic/acute leukemia predisposition syndromes through hematopoietic stem cell transplantation donors with thrombocytopenia.
|
|
Academic Article
|
High resolution methylome analysis reveals widespread functional hypomethylation during adult human erythropoiesis.
|
|
Academic Article
|
Immune reconstitution after combined haploidentical and umbilical cord blood transplant.
|
|
Academic Article
|
Hydroxymethylation at gene regulatory regions directs stem/early progenitor cell commitment during erythropoiesis.
|
|
Academic Article
|
IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cells.
|
|
Academic Article
|
Clofarabine-associated acute kidney injury in patients undergoing hematopoietic stem cell transplant.
|
|
Academic Article
|
Quantitative characterization of T-cell repertoire in allogeneic hematopoietic stem cell transplant recipients.
|
|
Academic Article
|
Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survival.
|
|
Academic Article
|
Frequency and Risk Factors Associated with Cord Graft Failure after Transplant with Single-Unit Umbilical Cord Cells Supplemented by Haploidentical Cells with Reduced-Intensity Conditioning.
|
|
Academic Article
|
The prognostic value of serum C-reactive protein, ferritin, and albumin prior to allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndromes.
|
|
Academic Article
|
Identifying Inherited and Acquired Genetic Factors Involved in Poor Stem Cell Mobilization and Donor-Derived Malignancy.
|
|
Academic Article
|
Epigenetically Aberrant Stroma in MDS Propagates Disease via Wnt/ß-Catenin Activation.
|
|
Academic Article
|
Antisense STAT3 inhibitor decreases viability of myelodysplastic and leukemic stem cells.
|
|
Academic Article
|
Reduced-Intensity Allogeneic Transplant for Acute Myeloid Leukemia and Myelodysplastic Syndrome Using Combined CD34-Selected Haploidentical Graft and a Single Umbilical Cord Unit Compared with Matched Unrelated Donor Stem Cells in Older Adults.
|
|
Academic Article
|
Cytokine-Regulated Phosphorylation and Activation of TET2 by JAK2 in Hematopoiesis.
|
|
Academic Article
|
Loss of Function of DOCK4 in Myelodysplastic Syndromes Stem Cells is Restored by Inhibitors of DOCK4 Signaling Networks.
|
|
Academic Article
|
Stem cell mutations can be detected in myeloma patients years before onset of secondary leukemias.
|
|
Grant
|
The role of Dock4 in normal and aberrant erythropoiesis
|